View in EDS PDF Full Text

FARMACOVIGILÂNCIA DE MEDICAMENTOS PSICOTRÓPICOS: IMPORTÂNCIA E DESAFIOS ATUAIS.

Saved in:
Bibliographic Details
Title: FARMACOVIGILÂNCIA DE MEDICAMENTOS PSICOTRÓPICOS: IMPORTÂNCIA E DESAFIOS ATUAIS.
Alternate Title: PHARMACOVIGILANCE OF PSYCHOTROPIC DRUGS: IMPORTANCE AND CURRENT CHALLENGES.
Authors: LIMA, GIOVANNA DE MORAIS1, TEMOTEO, MARIA CRISTINA SANDEGA1, ALVES, DANIELA FRANCO DA ROCHA1, SEIDLER, ÉDERSSON NAITZ2 edersson.naitz@gmail.com
Source: Brazilian Journal of Surgery & Clinical Research. mar-mai2026, Vol. 54 Issue 2, p47-51. 5p.
Subjects: DRUG monitoring, PATIENT safety, DRUG side effects, MEDICATION safety, PSYCHIATRIC drugs, MEDICATION errors, DISCLOSURE, PSYCHIATRIC treatment
Abstract (English): Psychotropic drugs are substances that act on the central nervous system, and they have been widely used in the treatment of psychiatric conditions. The study aims to analyze the importance of pharmacovigilance in psychotropic drugs monitoring, highlighting the challenges inherent to this process and how they can affect patient safety during pharmacotherapy. This is a literature review, carried out through the analysis of publications from the period between 2010 and 2024, available in the SciELO, LILACS and Google Scholar databases. The high number of adverse reactions reports resulting from psychotropic drugs, as well as prescription mistakes and errors during the prescriptions processing by pharmacists, impair the effectiveness in the treatment and patient safety. It is necessary to combat the underreporting of psychotropic drugs, encourage continued study by professionals and monitor the available data in order that more studies can be published and shared. [ABSTRACT FROM AUTHOR]
Abstract (Portuguese): Os fármacos psicotrópicos são substâncias que atuam no sistema nervoso central, sendo amplamente utilizados no tratamento de condições psiquiátricas. O estudo tem como objetivo analisar a importância da farmacovigilância no monitoramento de medicamentos psicotrópicos, destacando os desafios inerentes a esse processo e como eles podem prejudicar a segurança dos pacientes durante a farmacoterapia. Trata-se de uma revisão de literatura, realizada por meio da análise de publicações do período de 2010-2024, disponíveis nas bases de dados SciELO, LILACS e Google Acadêmico. Os altos números de notificações de reações adversas oriundas de psicotrópicos, assim como as falhas na prescrição e erros durante o processamento do receituário por parte dos profissionais farmacêuticos prejudicam a eficácia no tratamento e a segurança do paciente. É necessário combater a subnotificação de psicotrópicos, incentivar o estudo continuado por parte dos profissionais e realizar o acompanhamento dos dados disponíveis para que mais estudos sejam publicados e compartilhados. [ABSTRACT FROM AUTHOR]
Copyright of Brazilian Journal of Surgery & Clinical Research is the property of Master Editora and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:Psychotropic drugs are substances that act on the central nervous system, and they have been widely used in the treatment of psychiatric conditions. The study aims to analyze the importance of pharmacovigilance in psychotropic drugs monitoring, highlighting the challenges inherent to this process and how they can affect patient safety during pharmacotherapy. This is a literature review, carried out through the analysis of publications from the period between 2010 and 2024, available in the SciELO, LILACS and Google Scholar databases. The high number of adverse reactions reports resulting from psychotropic drugs, as well as prescription mistakes and errors during the prescriptions processing by pharmacists, impair the effectiveness in the treatment and patient safety. It is necessary to combat the underreporting of psychotropic drugs, encourage continued study by professionals and monitor the available data in order that more studies can be published and shared. [ABSTRACT FROM AUTHOR]
ISSN:23174404